Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma
Karine Flem‐Karlsen, Erin McFadden, Nasrin Omar, et al.
Molecular Cancer Therapeutics (2019) Vol. 19, Iss. 3, pp. 895-905
Open Access | Times Cited: 24

Showing 24 citing articles:

Targeting replication stress in cancer therapy
Alexandre André Balieiro Anastácio da Costa, Dipanjan Chowdhury, Geoffrey I. Shapiro, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 38-58
Closed Access | Times Cited: 193
AXL inhibition improves BRAF-targeted treatment in melanoma
Marta Nyakas, Karianne G. Fleten, Mads H. Haugen, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer
Mauricio Marquez-Palencia, L Herrera, Pravat Kumar Parida, et al.
Cancer Research (2024) Vol. 84, Iss. 5, pp. 675-687
Open Access | Times Cited: 8
AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
Kavya Ramkumar, C. Allison Stewart, Kasey R. Cargill, et al.
Molecular Cancer Research (2020) Vol. 19, Iss. 3, pp. 485-497
Open Access | Times Cited: 41
AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew
Almira Auyez, A. Emre Sayan, Marina Kriajevska, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4864-4864
Open Access | Times Cited: 38
Melanopsin (Opn4) is an oncogene in cutaneous melanoma
Leonardo Vinícius Monteiro de Assis, José Thalles Jocelino Gomes de Lacerda, Maria Nathália Moraes, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 19
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
Xun Hui Yeo, Vignesh Sundararajan, Zhengwei Wu, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 10
Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
Xirui Duan, Maochao Luo, Jian Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma
Jérémy H. Raymond, Zackie Aktary, Lionel Larue, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 706-706
Open Access | Times Cited: 14
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation
Dandan Xu, Deqiao Sun, Wei Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113497-113497
Closed Access | Times Cited: 17
Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma
Quan Liu, Wei Cui, Chao Yang, et al.
Aging (2021) Vol. 13, Iss. 15, pp. 19822-19834
Open Access | Times Cited: 16
LncRNA MSC‐AS1 motivates the development of melanoma by binding to miR‐302a‐3p and recruiting IGF2BP2 to elevate LEF1 expression
Yan Ma, Yuanyuan Jin, Can Li, et al.
Experimental Dermatology (2021) Vol. 30, Iss. 12, pp. 1764-1774
Closed Access | Times Cited: 11
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
Viola Hedrich, Kristina Breitenecker, Leila Djerlek, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5448-5448
Open Access | Times Cited: 11
Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
Luisa Maresca, Barbara Stecca, Laura Carrassa
Cells (2022) Vol. 11, Iss. 9, pp. 1466-1466
Open Access | Times Cited: 8
Mutational signatures are markers of drug sensitivity of cancer cells
Jurica Levatić, Marina Salvadores, Francisco Fuster‐Tormo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Applications of single‐cell sequencing for the field of otolaryngology: A contemporary review
Madeline Pyle, Michael Hoa
Laryngoscope Investigative Otolaryngology (2020) Vol. 5, Iss. 3, pp. 404-431
Open Access | Times Cited: 9
Rational Combinations of PARP Inhibitors with HRD-Inducing Molecularly Targeted Agents
Elizabeth K. Lee, Joyce F. Liu
Cancer treatment and research (2023), pp. 171-188
Closed Access | Times Cited: 3
AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization
Tuğçe Batur, Ayse Argundogan, Umur Keles, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13247-13247
Open Access | Times Cited: 6
Targeting Genome Stability in Melanoma—A New Approach to an Old Field
Marta Osrodek, Michał Woźniak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3485-3485
Open Access | Times Cited: 4
Investigating the function of NR4A3 in melanocyte DNA repair and cyto-protection
Ana Carolina De Almeida Pavarino
(2024)
Open Access
SOX10 modulated SMARCA4 dysregulation alleviates DNA replication stress in cutaneous melanoma
Xiangjian Fang, Keqiang Rao, Zhiyi Wei, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 23, pp. 5846-5857
Open Access | Times Cited: 2
Data from AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
Kavya Ramkumar, C. Allison Stewart, Kasey R. Cargill, et al.
(2023)
Open Access
The Role of AXL Receptor Tyrosine Kinase in Cancer Cell Plasticity and Therapy Resistance
Maria L. Lotsberg, Kjersti Davidsen, Stacey D’mello Peters, et al.
Springer eBooks (2022), pp. 307-327
Closed Access
The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
Ruby Yun‐Ju Huang, Xun Hui Yeo, Zhengwei Wu, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top